China Kidney Stones Market Size, Share, Trends and Forecasts 2031

Key Findings

• The China Kidney Stones Market is expanding due to the rising incidence of nephrolithiasis caused by changing dietary habits, dehydration, and sedentary lifestyles.
• Growing use of minimally invasive treatments such as ureteroscopy (URS), shock wave lithotripsy (SWL), and percutaneous nephrolithotomy (PCNL) is driving market growth.
• Increased awareness of preventive urology care and early diagnostic imaging is improving patient outcomes and treatment efficiency.
• The market is witnessing technological advancements in laser lithotripsy systems and stone retrieval devices.
• Rising prevalence of obesity, diabetes, and hypertension is contributing to higher kidney stone formation rates in China.
• Expansion of specialized urology centers and accessibility to advanced imaging modalities are strengthening healthcare infrastructure.
• However, high treatment costs, recurrence rates, and limited patient compliance with preventive therapies pose persistent challenges in China.

China Kidney Stones Market Size and Forecast

The China Kidney Stones Market is projected to grow from USD 2.8 billion in 2025 to USD 4.5 billion by 2031, registering a CAGR of 8.1% during the forecast period. Increasing prevalence of kidney stones due to dietary changes and lack of adequate hydration is a major factor driving market demand in China. Growing adoption of non-invasive and robotic-assisted urological procedures has improved patient recovery times and surgical precision. Hospitals and ambulatory surgical centers are integrating advanced diagnostic imaging techniques such as CT scans and ultrasound lithotripsy for accurate stone detection and fragmentation. With the rising adoption of laser-based lithotripsy and single-use disposable devices, the treatment landscape is becoming more efficient and patient-friendly.

Introduction

Kidney stones, or renal calculi, are hard deposits of minerals and salts formed inside the kidneys. The condition is prevalent worldwide and is influenced by factors such as high calcium intake, poor hydration, genetic predisposition, and metabolic disorders. In China, kidney stone cases are increasing due to climatic factors, fast-food consumption, and a growing elderly population. The condition causes severe pain, urinary infections, and potential kidney damage if untreated. Diagnosis and treatment involve advanced imaging, pharmacological therapy, and minimally invasive surgical procedures. Continuous innovation in endoscopic technologies and stone fragmentation systems is improving the efficiency of urological procedures, while preventive measures are gaining importance in healthcare frameworks.

Future Outlook

By 2031, the China Kidney Stones Market will transition toward precision urology supported by AI-driven diagnostics, personalized treatment algorithms, and robotic-assisted procedures. The focus will shift from reactive to preventive care, emphasizing early detection through metabolic screening and urine analysis. Pharmaceutical advancements will lead to improved stone dissolution drugs targeting calcium oxalate and uric acid stones. Tele-urology and mobile diagnostic apps will enhance patient monitoring and recurrence prevention. Furthermore, ongoing research into bioengineered kidney stone inhibitors and nanotechnology-based therapies will create breakthrough opportunities. The integration of digital health platforms with urological imaging and laser systems will position China as a leader in modern kidney stone management.

China Kidney Stones Market Trends

• Technological Advancements in Lithotripsy and Endourology
  The shift from conventional open surgery to non-invasive lithotripsy and endoscopic procedures is transforming the kidney stone treatment landscape in China. Laser lithotripsy and flexible ureteroscopy (fURS) have become preferred methods due to their precision and reduced recovery times. Integration of 3D imaging, miniaturized devices, and robotics is improving surgical outcomes and minimizing complications.

• Rising Prevalence of Lifestyle-Related Kidney Stones
  The growing incidence of obesity, hypertension, and diabetes in China is significantly increasing kidney stone formation rates. Poor hydration, high sodium diets, and increased animal protein consumption exacerbate risks. Public health campaigns and preventive programs are being implemented to mitigate these lifestyle-related causes.

• Adoption of AI and Imaging Technologies in Diagnosis
  Advanced imaging modalities such as dual-energy CT scans and ultrasound systems enhanced with AI-based analytics are improving stone detection accuracy. In China, AI algorithms are being deployed for automated stone composition analysis and size prediction, optimizing treatment selection.

• Growing Preference for Minimally Invasive and Day-Care Surgeries
  Patients and healthcare providers in China are increasingly opting for outpatient lithotripsy and minimally invasive endourological procedures. These approaches reduce hospital stays, infection risks, and costs, while providing faster recovery and better patient comfort.

• Emergence of Preventive Therapeutics and Nutraceuticals
  The rising recurrence rate of kidney stones is driving demand for preventive drugs and dietary supplements. Pharmaceutical companies in China are developing novel potassium citrate formulations, hydration enhancers, and nutraceutical products aimed at reducing recurrence rates.

Market Growth Drivers

• Rising Incidence of Kidney Stones Due to Changing Lifestyle Patterns
  The growing adoption of processed foods, dehydration due to warm climates, and high consumption of oxalate-rich diets have significantly increased kidney stone cases in China. These factors, coupled with sedentary habits, are driving healthcare systems to expand urological care facilities and awareness programs.

• Advancements in Minimally Invasive Surgical Procedures
  The development of laser-based lithotripsy systems, micro-ureteroscopes, and mini-PCNL devices has revolutionized kidney stone management. In China, healthcare providers are increasingly adopting these technologies to reduce complications, lower costs, and shorten hospital stays.

• Expansion of Diagnostic Imaging and Tele-Urology Services
  The widespread availability of high-resolution CT scanners and AI-enabled ultrasound systems has improved early detection and monitoring of renal stones. Telemedicine platforms in China are providing virtual consultations and remote follow-ups, making treatment more accessible and affordable.

• Increasing Geriatric Population and Comorbidity-Linked Stone Formation
  Elderly individuals in China face a higher risk of kidney stones due to reduced kidney function, dehydration, and chronic conditions such as diabetes. This demographic trend is leading to a steady rise in demand for advanced diagnostic and treatment solutions.

• Government Initiatives and Healthcare Infrastructure Development
  Public health campaigns promoting hydration and dietary balance are being implemented across China. Investments in healthcare infrastructure, especially in rural areas, are enabling better diagnosis and management of urological diseases.

• Pharmaceutical Innovation in Stone Dissolution and Pain Management
  Research into drugs that dissolve specific stone types and prevent recurrence is accelerating. In China, the development of oral pharmacotherapies targeting uric acid and cystine stones is expanding therapeutic options beyond surgical intervention.

Challenges in the Market

• High Recurrence Rate of Kidney Stones
  Despite successful treatment, recurrence remains a major issue, with 30–50% of patients developing new stones within five years. In China, lack of adherence to preventive measures such as hydration and dietary control exacerbates recurrence rates.

• Limited Access to Advanced Treatment Facilities in Rural Areas
  Access to high-end lithotripsy and endoscopic technologies remains concentrated in urban hospitals. In China, rural regions face shortages of trained urologists and specialized diagnostic equipment, restricting equitable treatment availability.

• High Cost of Treatment and Equipment
  Advanced procedures like laser lithotripsy and robotic-assisted surgeries are costly, limiting their accessibility. Smaller healthcare centers in China struggle to afford the necessary devices, hindering widespread adoption.

• Shortage of Skilled Urology Professionals
  The growing demand for urological procedures in China is outpacing the availability of trained specialists. Skill gaps in handling complex endourological and robotic systems are slowing procedural efficiency.

• Regulatory Hurdles and Long Approval Processes
  Stringent approval regulations for new devices and drugs delay market entry in China. Clinical validation requirements increase costs for manufacturers, affecting innovation timelines.

• Patient Non-Compliance and Lack of Preventive Awareness
  Many patients fail to maintain preventive regimens after treatment, including dietary restrictions and adequate hydration. Limited health education programs in China contribute to poor compliance, increasing recurrence and healthcare burden.

China Kidney Stones Market Segmentation

By Treatment Type

• Extracorporeal Shock Wave Lithotripsy (ESWL)

• Ureteroscopy (URS)

• Percutaneous Nephrolithotomy (PCNL)

• Medications and Dissolution Therapy

• Others (Dietary Management, Hydration Therapy)

By Stone Type

• Calcium Oxalate

• Uric Acid

• Struvite

• Cystine

• Others

By End-User

• Hospitals and Clinics

• Ambulatory Surgical Centers

• Specialty Urology Centers

• Homecare Settings

By Distribution Channel

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

Leading Key Players

• Boston Scientific Corporation

• Olympus Corporation

• Cook Medical Inc.

• Karl Storz SE & Co. KG

• Becton, Dickinson and Company (BD)

• Stryker Corporation

• Siemens Healthineers AG

• Dornier MedTech GmbH

• Richard Wolf GmbH

• Coloplast Group

Recent Developments

• Boston Scientific Corporation launched an advanced laser lithotripsy system in China designed for high-precision stone fragmentation.

• Olympus Corporation introduced next-generation flexible ureteroscopes in China with enhanced navigation and visualization capabilities.

• Cook Medical Inc. partnered with hospitals in China to expand access to single-use stone retrieval devices.

• Dornier MedTech GmbH announced the establishment of a lithotripsy research center in China to advance non-invasive stone treatment technologies.

• Stryker Corporation expanded its urology product portfolio in China with integrated imaging and laser treatment solutions for endourological procedures.

This Market Report Will Answer the Following Questions

1. What is the projected market size and CAGR of the China Kidney Stones Market by 2031?

2. Which treatment types and technologies are driving growth in China?

3. How are lifestyle changes, dietary habits, and comorbidities influencing kidney stone formation?

4. What challenges exist in terms of cost, access, and recurrence prevention in China?

5. Who are the leading players innovating in the kidney stones treatment market globally and regionally?